These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32599967)

  • 1. Impact of the APE1 Redox Function Inhibitor E3330 in Non-small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion.
    Manguinhas R; Fernandes AS; Costa JG; Saraiva N; Camões SP; Gil N; Rosell R; Castro M; Miranda JP; Oliveira NG
    Antioxidants (Basel); 2020 Jun; 9(6):. PubMed ID: 32599967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The APE1 redox inhibitor E3330 reduces collective cell migration of human breast cancer cells and decreases chemoinvasion and colony formation when combined with docetaxel.
    Guerreiro PS; Corvacho E; Costa JG; Saraiva N; Fernandes AS; Castro M; Miranda JP; Oliveira NG
    Chem Biol Drug Des; 2017 Oct; 90(4):561-571. PubMed ID: 28303665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Redox-Active Manganese(III) Porphyrin, MnTnBuOE-2-PyP
    Soares RB; Manguinhas R; Costa JG; Saraiva N; Gil N; Rosell R; Camões SP; Batinic-Haberle I; Spasojevic I; Castro M; Miranda JP; Guedes de Pinho P; Fernandes AS; Oliveira NG
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of apurinic/apyrimidinic endonuclease I's redox activity revisited.
    Zhang J; Luo M; Marasco D; Logsdon D; LaFavers KA; Chen Q; Reed A; Kelley MR; Gross ML; Georgiadis MM
    Biochemistry; 2013 Apr; 52(17):2955-66. PubMed ID: 23597102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration.
    Zou GM; Maitra A
    Mol Cancer Ther; 2008 Jul; 7(7):2012-21. PubMed ID: 18645011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
    Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
    Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APE1/Ref-1 prevents oxidative inactivation of ERK for G1-to-S progression following lead acetate exposure.
    Wang YT; Tzeng DW; Wang CY; Hong JY; Yang JL
    Toxicology; 2013 Mar; 305():120-9. PubMed ID: 23370007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin‑mediated mitophagy.
    Li Z; Wang Y; Wu L; Dong Y; Zhang J; Chen F; Xie W; Huang J; Lu N
    Oncol Rep; 2019 Dec; 42(6):2245-2254. PubMed ID: 31578585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
    Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
    Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.
    Ren T; Shan J; Qing Y; Qian C; Li Q; Lu G; Li M; Li C; Peng Y; Luo H; Zhang S; Zhang W; Wang D; Zhou SF
    Drug Des Devel Ther; 2014; 8():2517-29. PubMed ID: 25548514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
    Laev SS; Salakhutdinov NF; Lavrik OI
    Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APE1/Ref-1 redox function contributes to inflammatory pain sensitization.
    Zaky A; Bouali-Benazzouz R; Favereaux A; Tell G; Landry M
    Exp Neurol; 2018 Sep; 307():1-11. PubMed ID: 29772245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells.
    Jiang S; Zhu L; Tang H; Zhang M; Chen Z; Fei J; Han B; Zou GM
    Int J Oncol; 2015 Aug; 47(2):610-20. PubMed ID: 26081414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Characterization of New Chemical Entities Targeting Apurinic/Apyrimidinic Endonuclease 1 for the Prevention of Chemotherapy-Induced Peripheral Neuropathy.
    Kelley MR; Wikel JH; Guo C; Pollok KE; Bailey BJ; Wireman R; Fishel ML; Vasko MR
    J Pharmacol Exp Ther; 2016 Nov; 359(2):300-309. PubMed ID: 27608656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
    Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A
    J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
    Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of redox protein Ape1 in colon cancer stem cells.
    Lou D; Zhu L; Ding H; Dai HY; Zou GM
    Oncol Lett; 2014 Apr; 7(4):1078-1082. PubMed ID: 24944672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xiaoaiping combined with cisplatin can inhibit proliferation and invasion and induce cell cycle arrest and apoptosis in human ovarian cancer cell lines.
    Zheng AW; Chen YQ; Fang J; Zhang YL; Jia DD
    Biomed Pharmacother; 2017 May; 89():1172-1177. PubMed ID: 28320083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule activation of apurinic/apyrimidinic endonuclease 1 reduces DNA damage induced by cisplatin in cultured sensory neurons.
    Georgiadis MM; Chen Q; Meng J; Guo C; Wireman R; Reed A; Vasko MR; Kelley MR
    DNA Repair (Amst); 2016 May; 41():32-41. PubMed ID: 27078577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.